Started By
Message

re: New MS Drug Ocrevus Wins FDA Approval

Posted on 3/29/17 at 10:34 pm to
Posted by Hopeful Doc
Member since Sep 2010
14988 posts
Posted on 3/29/17 at 10:34 pm to
quote:

FWIW Basaglar costs a drop in the bucket less than Lantus.



Very true. But at least three are now three different companies making real once-daily insulins (not counting Levemir). It can only get better on the retail side, right?
Posted by ljhog
Lake Jackson, Tx.
Member since Apr 2009
19088 posts
Posted on 3/31/17 at 4:01 pm to
quote:

$65,000 A YEAR for just two treatments!!!

That is $21,000 cheaper than Merck's Rebif and possibly significantly more effective.
first pageprev pagePage 2 of 2Next pagelast page
refresh

Back to top
logoFollow TigerDroppings for LSU Football News
Follow us on Twitter, Facebook and Instagram to get the latest updates on LSU Football and Recruiting.

FacebookTwitterInstagram